BioCentury
ARTICLE | Company News

Merck KGaA acquires ProteoPlex

August 12, 2003 7:00 AM UTC

EMD Biosciences acquired ProteoPlex (St. Louis, Mo.), a provider of functional genomic and proteomic tools and services. EMD is a U.S. subsidiary of Merck KGaA (FSE:MRK). MRK said the acquisition give...